Learn / ADMA
NASDAQ: ADMA
Adma Biologics (ADMA) stock, explained like you're 5
Adma Biologics trades on the Nasdaq under the ticker ADMA. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 2.3 billion dollars.
- Ticker
- ADMA
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 2.3 billion dollars
Is Adma Biologics a small, medium or large cap company?
No. Adma Biologics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.3 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Adma Biologics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ADMA stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- ADMA Biologics (Nasdaq:ADMA) Stock Analysis (Simply Wall Street)
- ADMA Jan 2027 11.000 put (ADMA270115P00011000) interactive stock chart (Yahoo Finance UK)
- ADMA Biologics Inc. Stock Grades | ADMA (Barron's)
- No clotting events were reported for ADMA's immune globulin made with its updated process. (Stock Titan)
- ADMA Biologics (ADMA) Stock Still Looks Cheap Next To Its Earnings (Simply Wall Street)
Follow ADMA in your daily brief
Each trading day at 5 PM ET we post what happened to Adma Biologics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ADMA
Questions about Adma Biologics stock
What does Adma Biologics do?
Adma Biologics trades on the Nasdaq under the ticker ADMA. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 2.3 billion dollars.
What is the ticker symbol for Adma Biologics?
Adma Biologics trades under the ticker ADMA on the Nasdaq.
What is Adma Biologics's market cap?
Adma Biologics is a mid cap stock with a market cap of about 2.3 billion dollars.
How does Adma Biologics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ADMA stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ADMA stock every day?
Add ADMA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.